MedPath

Comparison of dexmedetomidine nebulization and ketamine nebulization for children taking MRI

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2020/06/025654
Lead Sponsor
IZAMS INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade 1&2

Age group 2 to 8 years

Male/female

Patients with normal airway

Exclusion Criteria

Age >8 years

General contraindications to MRI( cardiac pacemakers,neurostimulators,ferromagnetic implants,etc..)

Children with major respiratory and cardiac diseases and recent respiratory tract infections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome will be the sedation of the patient assessed by Richmond agitation sedation scaleTimepoint: Nebulization started 10-15 mins before procedure .vitals are monitored at T(5),T(10);T(20);T(30) min during nebulisation.sedation is then assessed using Richmond agitation sedation scale
Secondary Outcome Measures
NameTimeMethod
To assess outcomes between two groups;To note if any adverse effects like cough,bradycardia,hypotension are seen .Timepoint: Post sedation during separation from the parents asssesed by parent earl separation anxiety scale.Vitals monitored while MRI is going on post procedure vitals are monitored.
© Copyright 2025. All Rights Reserved by MedPath